Interactive Exchange™

The Expanding Role of the Pharmacist in HIV Prevention

What Do You Know About PrEP?

Meeting Slides

Clinical Practice Guidelines

Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations.

Centers for Disease Control and Prevention, 2014.

STD and HIV Screening Recommendations.

Centers for Disease Control and Prevention, 2017.

US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2014. A Clinical Practice Guideline.

Centers for Disease Control and Prevention, 2014.

ASHP Guidelines on Pharmacist Involvement in HIV Care.

Schafer JJ, et al. Am J Health Syst Pharm. 2016;73(7):468-494.

Clinical Resources

HIV Risk Reduction Estimator

Centers for Disease Control and Prevention, 2017.

PrEP Kit.

AIDS United, 2015.

HIV in the United States by Geographic Distribution.

Centers for Disease Control and Prevention, 2017.

Provider Information Sheet—PrEP During Conception, Pregnancy, and Breastfeeding.

Centers for Disease Control and Prevention.

State HIV Laws.

Centers for Disease Control and Prevention, 2017.

Taking a Sexual History.

NYC Health, 2015.

Transgender Health Learning Center.

University of California, San Francisco, 2017.

HIV Drug Interactions.

University of Liverpool (Web site), 2017.

Patient Resources

HIV Risk Reduction Estimator

Centers for Disease Control and Prevention, 2017.

Centers for Disease Control and Prevention (CDC): HIV Basics

The CDC is a division within the US Department of Health and Human Services (DHHS), the principal agency for protecting the health of all Americans. This comprehensive site provides extensive links to topics across the HIV-care continuum, including PrEP.

Pill-Reminder Smartphone Apps (Free)

Mango Health – Medicine Manager, Pill Reminder for iPhone

Mango Health for Android

Medisafe Pill Reminder, Rx, & Medicine Tracker for iPhone

Medisafe Meds & Pill Reminder for Android

Positively Aware

Positively Aware, created by TPAN (Test Positive Aware Network), is a source of HIV-treatment news for consumers, as well as an educational tool for HIV caregivers. The site features PrEP resources, including videos for MSM and transgender people.

PrEP for U.S. Women: A Collection of Resources

HIVE (Web site).
HIVE provides preconception and prenatal resources for women and couples affected by HIV.

PrEP Locator

PrEP Locator is an online directory of public and private-practice providers of HIV preexposure prophylaxis (PrEP) in the United States. The site includes a map-based widget for ease of locating PrEP services.

Suggested Readings

HIV providers’ likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.

Adams LM, Balderson BH. AIDS Care. 2016;28(9):1154-1158.

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.

Baeten JM, et al. N Engl J Med. 2012;367(5):399-410.

Pharmacists as providers of HIV preexposure prophylaxis.

Bruno C, Saberi P. Int J Clin Pharm. 2012;34(6):803-806.

Effectiveness of prevention strategies to reduce the risk of acquiring or transmitting HIV.

Centers for Disease Control and Prevention, 2017.

Innovative CDC effort expands HIV testing into pharmacies.

Centers for Disease Control and Prevention, 2012.

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Choopanya K, et al. Lancet. 2013;381(9883):2083-2090.

Behavioral HIV risk reduction among people who inject drugs: meta-analytic evidence of efficacy.

Copenhaver MM, et al. J Subst Abuse Treat. 2006;31(2):163-171.

Pharmacist-provided rapid HIV testing in two community pharmacies.

Darin KM, et al. J Am Pharm Assoc (2003). 2015;55(1):81-88.

Integrating antiretroviral strategies for human immunodeficiency virus prevention: post- and pre-exposure prophylaxis and early treatment.

Grant RM, Smith DK. Open Forum Infect Dis. 2015;2(4):ofv126.

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Grant RM, et al. N Engl J Med. 2010;363(27):2587-2599.

MSM estimation state profiles.

Grey J, Emory Coalition for Applied Modeling for Prevention (CAMP).

Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

McCormack S, et al. Lancet. 2016;387(10013):53-60.

What is PrEP?

PrEP REP project.

Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.

Shaeer KM, et al. J Am Pharm Assoc (2003). 2014;54(6):610-617.

Interactive Presentation

PrEP: HIV Pre-Exposure Prophylaxis

Narrated by Richard A. Elion, MD

The Expanding Role of the Pharmacist in HIV Prevention

What Do You Know About PrEP?

Relevant Resources

PrEP for Your Patients’ Needs

The PCPs Role in Preventing HIV

Value-Based HIV Formularies

Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care

Hepatitis C is Curable

Got it? Treat it!

Real-World Issues in HIV Prevention & Treatment

The Critical Role of the Community Pharmacist


Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.

Evolving Models of HIV Care

Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice

Clinical Issues in Chronic Liver Disease

Hot Topics in HBV, HCV, and NASH

Evolving Models of HIV Care

Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice

Assessing Your Patients for HCV and HIV

Why It Matters in OB/GYN Practice Today

HIV as a Chronic Disease

A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities

The Pursuit of Hepatitis C Elimination

How the Pharmacist Can Make a Difference

Trends in Infectious Diseases: Updates on Treatment & Prevention Strategies for HIV and HCV

Understanding the Growing Syndemic — Opioids, HCV, and HIV

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

Evolving Models of HIV Care (Volume 3)

The Rapid ART Standard of Care: From Evidence to Healthcare Equity

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes


Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

Challenges and Opportunities in HIV

Practical Solutions Across the Spectrum of Care

Expanding HIV Prevention in Colorado—and Nationwide

A PEP/PrEP Training Guide for Pharmacists

Treating Hepatitis C in the Primary Care Setting

A Critical Step Toward HCV Elimination

Honing Clinical Skills in HIV Treatment

Considering the Patient, the Provider, and the Science

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies

Treating Hepatitis C in the Primary Care Setting

Establishing Clinical Readiness Through Mentored Learning

Clinical Updates in COVID-19

Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment

Monoclonal Antibodies for COVID-19

An Update on Best Practices

Monoclonal Antibodies for COVID-19

New Avenues to Pre-Exposure Prophylaxis

Virologic Failure in HIV

An Updated Clinician’s Guide to Assessment and Management

Applying HIV Advances in Practice

What the Pharmacist Needs to Know

Buffing Up on New and Emerging ART

A Look at the Changing HIV Playing Field

Pharmacy PrEP Education

A “How To” Series Spanning Policy to Practice


Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention

Long-Acting Injectable PrEP:

Bringing HIV Prevention to a New Level

PrEParing to End the Epidemic

Optimizing HIV Prevention in Primary Care

A Call to Action

Monoclonal Antibodies for the Prevention and Treatment of COVID-19

Answers to Everyday Practice Challenges in HIV Medicine

A Phone-a-Friend CME Series – Volume 2

What’s New in the Management of COVID-19

Incorporating New Data and Updated Guidelines Into Daily Practice